These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients. Hirai T, Furusawa M, Omoto K, Ishida H, Tanabe K. Transplantation; 2014 Aug 27; 98(4):443-50. PubMed ID: 24717219 [Abstract] [Full Text] [Related]
4. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation. Heilman RL, Nijim A, Desmarteau YM, Khamash H, Pando MJ, Smith ML, Chakkera HA, Huskey J, Valdez R, Reddy KS. Transplantation; 2014 Dec 27; 98(12):1310-5. PubMed ID: 24879384 [Abstract] [Full Text] [Related]
5. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation. Huang Y, Ramon D, Luan FL, Sung R, Samaniego M. Clin Transpl; 2012 Dec 27; ():247-56. PubMed ID: 23721029 [Abstract] [Full Text] [Related]
6. De novo donor specific antibodies and patient outcomes in renal transplantation. DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA. Clin Transpl; 2011 Dec 27; ():351-8. PubMed ID: 22755430 [Abstract] [Full Text] [Related]
8. Changes in successive measures of de novo donor-specific anti-human leukocyte antigen antibodies intensity and the development of allograft dysfunction. Dieplinger G, Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Harland RC, Terasaki PI. Transplantation; 2014 Nov 27; 98(10):1097-104. PubMed ID: 24911039 [Abstract] [Full Text] [Related]
9. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Li X, Ishida H, Yamaguchi Y, Tanabe K. Transpl Int; 2008 Dec 27; 21(12):1145-52. PubMed ID: 18803618 [Abstract] [Full Text] [Related]
10. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C. Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487 [Abstract] [Full Text] [Related]
15. Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation. Wiebe C, Nickerson P. Curr Opin Organ Transplant; 2013 Aug 27; 18(4):470-7. PubMed ID: 23695596 [Abstract] [Full Text] [Related]